Mixture of probiotic bacteria strains for use in the treatment of allergic asthma and with recurrent wheezing, preferably in paediatrict subjects
AssigneeProbiotical S.P.A.
InventorsVera MOGNA, Marco PANE, Angela AMORUSO
Life of this patent
Estimating the term…
Abstract
An isolated strain of bacteria Bifidobacterium breve (B632) DSM 24706 and related mixtures, compositions and methods for treatment of a disorder or an ailment or a disease of the respiratory airways including asthma and dyspnoea are described. The composition comprising the mixture includes at least one physiologically and/or pharmacologically acceptable additive and/or technological excipient. The isolated strain mixture and composition can be administered to paediatric subjects having a disorder or an ailment or a disease of the respiratory airways.
Claims20
A method comprising administering to a subject an isolated strain of bacteria belonging to the species Bifidobacterium breve deposited on 7 Apr. 2011, at Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ), as Bifidobacterium breve (B632) and having accession number DSM 24706 in an effective amount for treatment of a disorder or an ailment or a disease of the respiratory airways of the subject.
A mixture comprising
- an isolated strain of bacteria deposited on 23 Jul. 2009, at Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ), as Lactobacillus salivarius (LS01) and having accession number DSM 22775, and
- an isolated strain of bacteria deposited on 7 Apr. 2011, at Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ), as Bifidobacterium breve (B632) and having accession number DSM 24706.
Dependencies are inferred from the claim text.